Luke Howard
Imperial College London
H-index: 63
Europe-United Kingdom
Top articles of Luke Howard
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype | Clinical Research in Cardiology | Matteo Toma Giulio Savonitto Carlo Maria Lombardi Edoardo Airò Mauro Driussi | 2024/4/15 |
Cardiac Effort Is Less Variable Than Six-minute Walk Distance, Correlates With Hemodynamics and Is Consistent With REVEAL 2.0 Risk Score in a Sub-study of the TORREY Phase 2 … | DJ Lachant R Osterhout MM Chakinala V Franco JW Mcconnell | 2024/5 | |
Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians | Advances in Respiratory Medicine | Joanna Pepke-Zaba Luke Howard David G Kiely Shruti Sweeney Martin Johnson | 2024/1/9 |
Systematic pulmonary embolism follow-up: why we should all do it! | Luke S Howard Laura C Price | 2024/3/1 | |
Therapeutic Implications of Plasma Proteome Clusters in Pulmonary Hypertension | A Boucly LS Howard MJC Humbert O Sitbon D Wang | 2024/5 | |
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension | Nature Communications | Anna Ulrich Yukyee Wu Harmen Draisma John Wharton Emilia M Swietlik | 2024/1/6 |
Long-term effects of pulmonary endarterectomy on pulmonary hemodynamics, cardiac function, and exercise capacity in chronic thromboembolic pulmonary hypertension | The Journal of Heart and Lung Transplantation | Azar Kianzad Andrea Baccelli Natalia J Braams Stine Andersen Jessie van Wezenbeek | 2024/4/1 |
Comparison of contemporary risk scores in all groups of pulmonary hypertension-a PVRI GoDeep meta-registry analysis | Chest | Athiththan Yogeswaran Henning Gall Meike Fünderich Martin R Wilkins Luke Howard | 2024/3/19 |
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease | Nature Immunology | Felicity Liew Claudia Efstathiou Sara Fontanella Matthew Richardson Ruth Saunders | 2024/4/8 |
Interim Results From the Phase 1B and Phase 2 TORREY Open-label Extension Study of Seralutinib in Pulmonary Arterial Hypertension (PAH) | O Sitbon S Sahay P Escribano Subías RL Zolty JF Kingrey | 2024/5 | |
Unmet need in PH-ILD: A clinician survey of real-world management of PH-ILD in Europe | ERJ Open Research | David Montani José M Cifrián Raquel P Rojo Hilario Nunes Federica Meloni | 2024/1/1 |
TORREY Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension (PAH): Circulating Biomarkers of Proliferation, Inflammation, and Fibrosis Improve With Treatment | HA Ghofrani R Osterhout RL Benza RN Channick KM Chin | 2024/5 | |
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised … | The Lancet Child & Adolescent Health | Saul N Faust Richard Haynes Christine E Jones Natalie Staplin Elizabeth Whittaker | 2024/3/1 |
Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism | American Journal of Respiratory and Critical Care Medicine | James Liley Michael Newnham Marta Bleda Katherine Bunclark William Auger | 2024/3/12 |
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo … | The Lancet Respiratory Medicine | Hossein-Ardeschir Ghofrani Gérald Simonneau Andrea M D'Armini Peter Fedullo Luke S Howard | 2024/4/1 |
Evaluation of Seralutinib Treatment Effect Across Four Risk Tools in the TORREY Study in Pulmonary Arterial Hypertension (PAH) | The Journal of Heart and Lung Transplantation | RL Benza R Osterhout S Hoffman RT Zamanian AR Hemnes | 2024/4/1 |
ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport | Cardiovascular Research | Bin Liu Mujahid Azfar Ekaterina Legchenko James A West Shaun Martin | 2024/4/16 |
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose‐response and clinical efficacy … | Pulmonary Circulation | Frances Varian Jennifer Dick Christian Battersby Stefan Roman Jenna Ablott | 2024/1 |
Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID) study | International Journal of Epidemiology | Omer Elneima Hamish JC McAuley Olivia C Leavy James D Chalmers Alex Horsley | 2024/2/1 |
PH-ILD management and unmet need in Europe: a clinician survey | Luke Howard Stefano Ghio Federica Meloni John Cannon Hilario Nunes | 2023/9/9 |
Co-Authors
